drugset / Trial / NCT02728323

Transversus Abdominis Plane Block in the Management of Acute Postoperative Pain Syndrome After Caesarean Section

NCT02728323

Phase 3 Terminated 96 enrolled Emiliano Petrucci
RandomizedParallel-groupTriple-blindPrevention

Summary

In many countries, caesarean section (CS) rates have been increasing. The international literature is unclear regarding the analgesic efficacy of the transversus abdominis plane block (TAPB) after a CS. In particular, no clinical trials exist in which the correct method of performing this block has been matched with the obtained analgesic effect after a CS. The primary goal of the study was to determine whether a correctly performed ultrasound-guided TAPB (USG-TAPB) could provide patients who underwent a CS with better control of acute postoperative pain during the first 72 hours after surgery

Timeline

Start
2013-10
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levobupivacaine Other / unclassified 100 mg Intramuscular

Indications

No indication recorded.